Skip to content

Opening book details…

Can I read Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application on EtoBox?

Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application by Davoud Jafari-Gharabaghlou; Mehdi Dadashpour; Omid Joodi khanghah; Elnaz Salmani-Javan; Nosratollah Zarghami is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application about?

Aim: Folate receptor expression increase up to 30% in breast cancer cells and could be used as a possible ligand to couple to folate-functionalized nanoparticles. Metformin (Met) is an anti-hyperglycemic agent whose anti-cancer properties have been formerly reported. Consequently, in the current study, we aimed to synthesize and characterize folate-functionalized PLGA-PEG NPs loaded with Met and evaluate the anti-cancer effect against the MDA-MB-231 human breast cancer cell line. Methods: FA-PLGA-PEG NPs were synthesized by employing the W1/O/W2 technique and their physicochemical features were evaluated by FE-SEM, TEM, FTIR, and DLS methods. The cytotoxic effects of free and Nano-encapsulated drugs were analyzed by the MTT technique. Furthermore, RT-PCR technique was employed to assess the expression levels of apoptotic and anti-apoptotic genes. Result: MTT result indicated Met-loaded FA-PLGA-PEG NPs exhibited cytotoxic effects in a dose-dependently manner and had more cytotoxic effects relative to other groups. The remarkable down-regulation (hTERT and Bcl-2) and up-regulation (Caspase7, Caspase3, Bax, and p53) gene expression were shown in treated MDA-MB-231 cells with Met-loade

Who reads Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Davoud Jafari-Gharabaghlou; Mehdi Dadashpour; Omid Joodi khanghah; Elnaz Salmani-Javan; Nosratollah Zarghami
Publisher
Springer Science and Business Media LLC
Published
2023
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Davoud Jafari-Gharabaghlou; Mehdi Dadashpour; Omid Joodi khanghah; Elnaz Salmani-Javan; Nosratollah Zarghami

Browse all works by Davoud Jafari-Gharabaghlou; Mehdi Dadashpour; Omid Joodi khanghah; Elnaz Salmani-Javan; Nosratollah Zarghami